Docking studies to evaluate the biological activities of the Co(II) and Ni(II) complexes containing the triazine unit: supported by structural, spectral, and theoretical studies
- 2 December 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Coordination Chemistry
- Vol. 71 (23) , 3893-3911
Abstract
Two complexes of 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine (L), [Co(L)2(NO3)2] (1) and [Ni(L)2(NO3)2] (2), were prepared and identified along with L by elemental analysis, FT-IR, UV-Vis and 1H NMR spectroscopies and single-crystal X-ray diffraction. All coordination modes of the 1,2,4-triazine unit and also of the nitrato ligand in coordination with cobalt and nickel atoms were studied by analysis of the Cambridge Structural Database (CSD) to compare with the new results. X-ray structure analysis of complexes 1 and 2 revealed that the metal atom in both complexes has an octahedral geometry with MN4O2 environment (M: Co (1), Ni (2)). The ligand acts as a bidentate NtzNpy-donor and forms a five-membered planar chelate ring. In addition to the hydrogen bonds, the crystal network is stabilized by π–π stacking interactions between pyridine rings of the ligands of adjacent complexes. The thermodynamic stability of the two conformational isomers of the 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine and their charge distribution patterns were studied by DFT and NBO analysis, respectively. The ability of the uncoordinated ligand conformers and complexes 1 and 2 to interact with nine selected biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) was investigated by docking calculations and compared with that of doxorubicin. Also an analogue of the ligand in which the furyl rings are replaced by phenyl groups is included in these studies.Keywords
This publication has 67 references indexed in Scilit:
- Comparing the Suitability of Autodock, Gold and Glide for the Docking and Predicting the Possible Targets of Ru(II)-Based Complexes as Anticancer AgentsMolecules, 2013
- Heterodinuclear ruthenium(ii)–cobalt(iii) complexes as models for a new approach to selective cancer treatmentDalton Transactions, 2012
- Synthesis and structural characterization of new dinuclear silver(I) complexes: Different coordination modes of substituted 1,2,4-triazine ligandsJournal of Molecular Structure, 2011
- 5-Arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase InhibitorsJournal of Medicinal Chemistry, 2007
- Synthesis and structural charaterization of a Cu(II) complex with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine (PDPT)Journal of Coordination Chemistry, 2005
- Determination of Fe(II) and total iron in natural waters with 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine (PDT)Analytica Chimica Acta, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Chromogenic reagents for iron(II): Studies in the 1,2,4-triazine seriesAnalytica Chimica Acta, 1996